Healthcare costs differ for metastatic castration-resistant prostate cancer

PharmacoEconomics & Outcomes News ◽

10.1007/s40274-020-6881-7 ◽

2020 ◽

Vol 855 (1) ◽

pp. 16-16

Keyword(s):

Prostate Cancer ◽

Healthcare Costs ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

Predictors of survival, healthcare resource utilization, and healthcare costs in veterans with non-metastatic castration-resistant prostate cancer

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2020.07.002 ◽

2020 ◽

Vol 38 (12) ◽

pp. 930.e13-930.e21

Author(s):

Stephen J. Freedland ◽

Dominic Pilon ◽

Rachel H. Bhak ◽

Patrick Lefebvre ◽

Sophia Li ◽

...

Keyword(s):

Prostate Cancer ◽

Resource Utilization ◽

Healthcare Costs ◽

Healthcare Resource ◽

Healthcare Resource Utilization ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

Healthcare Costs for Metastatic Castration-Resistant Prostate Cancer Patients Treated with Abiraterone or Enzalutamide

PharmacoEconomics - Open ◽

10.1007/s41669-021-00307-1 ◽

2021 ◽

Author(s):

Dikshyanta Rana ◽

Claudia Geue ◽

Kelly Baillie ◽

Jiafeng Pan ◽

Tanja Mueller ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Healthcare Costs ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

Treatment-Related Healthcare Costs of Metastatic Castration-Resistant Prostate Cancer in Germany: A Claims Data Study

PharmacoEconomics - Open ◽

10.1007/s41669-020-00219-6 ◽

2020 ◽

Author(s):

Kristine Kreis ◽

Dirk Horenkamp-Sonntag ◽

Udo Schneider ◽

Jan Zeidler ◽

Gerd Glaeske ◽

...

Keyword(s):

Prostate Cancer ◽

Healthcare Costs ◽

Claims Data ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

Neuroendocrine secretory profiles are not associated with treatment response to Lu-177-PSMA-617 radioligand therapy in patients with advanced metastatic castration-resistant prostate cancer

10.1055/s-0040-1708342 ◽

2020 ◽

Author(s):

T Derlin ◽

R Werner ◽

C Henkenberens ◽

TL Ross ◽

FM Bengel

Keyword(s):

Prostate Cancer ◽

Treatment Response ◽

Castration Resistant Prostate Cancer ◽

Radioligand Therapy ◽

Castration Resistant

Download Full-text

Prostate specific membrane antigen targeted radioligand therapy of metastatic castration-resistant prostate cancer using Lu-177 PSMA-617: safety, efficacy and dosimetry in comparison with Lu-177 PSMA I&T

Endocrine Abstracts ◽

10.1530/endoabs.47.oc32 ◽

2016 ◽

Author(s):

Harshad R. Kulkarni ◽

Aviral Singh ◽

Christiane Schuchardt ◽

Karin Niepsch ◽

Richard P. Baum

Keyword(s):

Prostate Cancer ◽

Prostate Specific Membrane Antigen ◽

Castration Resistant Prostate Cancer ◽

Radioligand Therapy ◽

Castration Resistant ◽

Specific Membrane

Download Full-text

New combination therapies for castration-resistant prostate cancer

Oncology Abstracts ◽

10.1530/oncolabs.1.p031 ◽

2019 ◽

Author(s):

Mitchell G Lawrence ◽

Laura H Porter ◽

Daisuke Obinata ◽

Shahneen Sandhu ◽

Luke A Selth ◽

...

Keyword(s):

Prostate Cancer ◽

New Combination ◽

Combination Therapies ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

The role of microbiota in driving castration-resistant prostate cancer

10.26226/morressier.5f69edb69b74b699bf38c5cf ◽

2020 ◽

Author(s):

Arianna Calcinotto

Keyword(s):

Prostate Cancer ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

FDA approves darolutamide for non-metastatic castration-resistant prostate cancer

Case Medical Research ◽

10.31525/cmr-1904aca ◽

2019 ◽

Author(s):

Keyword(s):

Prostate Cancer ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

A Trial Evaluating the Efficacy and Safety of HC-1119 Soft Capsules in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Case Medical Research ◽

10.31525/ct1-nct03851640 ◽

2019 ◽

Author(s):

Keyword(s):

Prostate Cancer ◽

Efficacy And Safety ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

177Lu-PSMA-617 Therapy and Olaparib in Patients With Metastatic Castration Resistant Prostate Cancer

Case Medical Research ◽

10.31525/ct1-nct03874884 ◽

2019 ◽

Author(s):

Keyword(s):

Prostate Cancer ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text